The anticancer efficiency of the xenogeneic vaccine and the indication for its use
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | T. V. Symchych, N. I. Fedosova, O. M. Karaman, L. M. Yevstratieva, H. S. Lisovenko, I. M. Voyeykova, H. P. Potebnia |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Experimental Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000294096 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
The anticancer efficiency of the xenogeneic vaccine and the indication for its use
by: Symchych, T.V., et al.
Published: (2014)
by: Symchych, T.V., et al.
Published: (2014)
Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
by: T. V. Symchych, et al.
Published: (2015)
by: T. V. Symchych, et al.
Published: (2015)
Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
by: Symchych, T.V., et al.
Published: (2015)
by: Symchych, T.V., et al.
Published: (2015)
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma
by: Symchych, T.V., et al.
Published: (2017)
by: Symchych, T.V., et al.
Published: (2017)
Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16
by: N. I. Fedosova, et al.
Published: (2015)
by: N. I. Fedosova, et al.
Published: (2015)
Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16
by: Fedosova, N.I., et al.
Published: (2015)
by: Fedosova, N.I., et al.
Published: (2015)
Comparison of the efficacy of different regimens of xenogeneic cancer vaccine on models of metastatic tumor growth
by: N. I. Fedosova, et al.
Published: (2017)
by: N. I. Fedosova, et al.
Published: (2017)
Use of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16?melanoma-bearing mice
by: I. M. Voeykova, et al.
Published: (2014)
by: I. M. Voeykova, et al.
Published: (2014)
Use of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16‑melanoma-bearing mice
by: Voeykova, І.М., et al.
Published: (2014)
by: Voeykova, І.М., et al.
Published: (2014)
The effects of early postoperative immunization with xenogeneic embryo proteins on Lewis lung carcinoma model
by: Symchych, T.V., et al.
Published: (2018)
by: Symchych, T.V., et al.
Published: (2018)
Anticancer efficacy of allogeneic vaccine modified with progenitor neural cells supernatant in rats with glioma 101.8
by: L. D. Liubich, et al.
Published: (2015)
by: L. D. Liubich, et al.
Published: (2015)
Experimental study of the efficacy of combined use of cancer vaccine and interferon
by: Potebnya, G.P., et al.
Published: (2007)
by: Potebnya, G.P., et al.
Published: (2007)
Antitumor and antimetastatic efficiency of antitumor vaccine and amixin combined action in mice with Lewis lung carcinoma
by: G. V. Didenko, et al.
Published: (2016)
by: G. V. Didenko, et al.
Published: (2016)
ДОСЛІДЖЕННЯ IN VIVO ПОТЕНЦІЙНИХ МЕХАНІЗМІВ РЕПОЛЯРИЗАЦІЇ МАКРОФАГІВ НА ТЛІ ПУХЛИННОГО РОСТУ
by: FEDOSOVA, N., et al.
Published: (2024)
by: FEDOSOVA, N., et al.
Published: (2024)
Efficacy of anticancer autovaccine with standard anticancer treatmentcombination in breast cancer patients (analysis of 10-year surveillance data)
by: V. V. Zajchuk, et al.
Published: (2015)
by: V. V. Zajchuk, et al.
Published: (2015)
Fullerene C60 and its derivatives as anticancer agents: problems and prospects
by: S. V. Prylutska, et al.
Published: (2012)
by: S. V. Prylutska, et al.
Published: (2012)
Devitalized xenogenic arteries: transplantation experience
by: E. V. Shevchenko, et al.
Published: (2014)
by: E. V. Shevchenko, et al.
Published: (2014)
The effect of nanosecond ultrawideband electromagnetic radiation on xenogeneic erythrocytes
by: Gordienko, E.A., et al.
Published: (2001)
by: Gordienko, E.A., et al.
Published: (2001)
Prospects for using the phenomenon of macrophages plasticity to evaluate the efficiency of cancer therapy
by: O. O. Kruts, et al.
Published: (2020)
by: O. O. Kruts, et al.
Published: (2020)
Substantiation of the diffusion model for innovation implementation and its application to the spread of vaccinations
by: V. M. Horbachuk, et al.
Published: (2022)
by: V. M. Horbachuk, et al.
Published: (2022)
Anticancer therapy and apoptosis imaging
by: Yalcin, T.J., et al.
Published: (2012)
by: Yalcin, T.J., et al.
Published: (2012)
Budget capacite of Ukraine for financing of COVID-19 vaccination in the emerging global vaccine market
by: V. M. Heiets, et al.
Published: (2021)
by: V. M. Heiets, et al.
Published: (2021)
Influence of xenogeneic mesenchymal stem cells transplantation on atrophic rhinitis in mice
by: O. H. Deriabina, et al.
Published: (2015)
by: O. H. Deriabina, et al.
Published: (2015)
Coronavirus S antigen as a marker of effective vaccination
by: V. H. Spyrydonov, et al.
Published: (2021)
by: V. H. Spyrydonov, et al.
Published: (2021)
Mechanomagnetic reactor for activation of anticancer drugs
by: V. E. Orel, et al.
Published: (2014)
by: V. E. Orel, et al.
Published: (2014)
Anticancer substances of mushroom origin
by: T. S. Ivanova, et al.
Published: (2014)
by: T. S. Ivanova, et al.
Published: (2014)
Tissue engineering of vascular/valvular equivalents on the base of the xenogeneic decellularized matrix
by: M. V. Savchuk
Published: (2014)
by: M. V. Savchuk
Published: (2014)
Tissue engineering of vascular/valvular equivalents on the base of the xenogeneic decellularized matrix
by: Savchuk, M.V.
Published: (2014)
by: Savchuk, M.V.
Published: (2014)
Characterization of vaccine and field IBDV strains in Ukraine for proper vaccine selection for disease prevention
by: Pastyria, A.S., et al.
Published: (2018)
by: Pastyria, A.S., et al.
Published: (2018)
Devilitalized Xenogeneic Vascular Grafts in 14 Months Post Transplantation
by: D. V. Byzov, et al.
Published: (2012)
by: D. V. Byzov, et al.
Published: (2012)
Modelling the Optimal Schemes of Population Vaccination Using Epidemiological Data
by: Soloviov, S., et al.
Published: (2020)
by: Soloviov, S., et al.
Published: (2020)
Modelling the Optimal Schemes of Population Vaccination Using Epidemiological Data
by: S. Soloviov, et al.
Published: (2019)
by: S. Soloviov, et al.
Published: (2019)
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)
by: Potebnya, G.P., et al.
Published: (2009)
Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo
by: L. Gevorkyan, et al.
Published: (2014)
by: L. Gevorkyan, et al.
Published: (2014)
Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo
by: Gevorkyan, L., et al.
Published: (2014)
by: Gevorkyan, L., et al.
Published: (2014)
Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer
by: Skachkova, O.V., et al.
Published: (2013)
by: Skachkova, O.V., et al.
Published: (2013)
Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer
by: O. V. Skachkova, et al.
Published: (2013)
by: O. V. Skachkova, et al.
Published: (2013)
Antiproteases vaccine the flu in the experiment
by: V. A. Divocha
Published: (2015)
by: V. A. Divocha
Published: (2015)
Biotechnological research in the creation and production of antirabic vaccines
by: Yu. M. Krasnopolsky, et al.
Published: (2021)
by: Yu. M. Krasnopolsky, et al.
Published: (2021)
Properties of pyrrol derivatives as potential anticancer compounds of a new generation
by: H. M. Kuznietsova, et al.
Published: (2014)
by: H. M. Kuznietsova, et al.
Published: (2014)
Similar Items
-
The anticancer efficiency of the xenogeneic vaccine and the indication for its use
by: Symchych, T.V., et al.
Published: (2014) -
Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
by: T. V. Symchych, et al.
Published: (2015) -
Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
by: Symchych, T.V., et al.
Published: (2015) -
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma
by: Symchych, T.V., et al.
Published: (2017) -
Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16
by: N. I. Fedosova, et al.
Published: (2015)